Ubs Group Ag Organon & Co. Transaction History

Ubs Group Ag

$397 Billion
Q1 2024

A detailed history of Ubs Group Ag transactions in Organon & Co. stock. As of the latest transaction made, Ubs Group Ag holds 72,100 shares of OGN stock, worth $1.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

72,100

Previous 543,331 86.73%

Holding current value

$1.45 Million

Previous $7.83 Million 82.7%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$13.78 - $18.8 $1.2 Million - $1.64 Million	87,120 Added 16.03%	630,451 $11.9 Million
Q4 2023 Feb 09, 2024	SELL	$10.95 - $17.32 $1.25 Million - $1.98 Million	-114,581 Reduced 17.42%	543,331 $7.83 Million
Q3 2023 Nov 09, 2023	BUY	$16.59 - $23.77 $5.12 Million - $7.33 Million	308,470 Added 88.28%	657,912 $11.4 Million
Q2 2023 Aug 11, 2023	SELL	$19.27 - $24.63 $199,868 - $255,462	-10,372 Reduced 2.88%	349,442 $7.27 Million
Q1 2023 May 12, 2023	SELL	$21.42 - $32.08 $7.15 Million - $10.7 Million	-334,003 Reduced 48.14%	359,814 $8.46 Million

Q4 2022 Feb 08, 2023	BUY	$23.31 - $28.61 $2.35 Million - $2.89 Million	101,023 Added 17.04%	693,817 $19.4 Million
Q3 2022 Nov 10, 2022	BUY	$23.4 - $34.25 $3.44 Million - $5.04 Million	147,065 Added 32.99%	592,794 $13.9 Million
Q2 2022 Aug 10, 2022	BUY	$31.66 - $38.9 $522,548 - $642,044	16,505 Added 3.85%	445,729 $15 Million
Q1 2022 May 16, 2022	SELL	$30.45 - $39.36 $2.42 Million - $3.13 Million	-79,572 Reduced 15.64%	429,224 $15 Million
Q4 2021 Feb 14, 2022	BUY	$28.67 - $37.13 $421,076 - $545,328	14,687 Added 2.97%	508,796 $15.5 Million
Q3 2021 Nov 15, 2021	SELL	$28.63 - $35.64 $8.84 Million - $11 Million	-308,873 Reduced 38.47%	494,109 $16.2 Million
Q2 2021 Aug 13, 2021	BUY	$28.45 - $38.0 $22.8 Million - $30.5 Million	802,982 New	802,982 $24.3 Million

Others Institutions Holding OGN

# of Institutions

788

Shares Held

190M

Call Options Held

2.46M

Put Options Held

2.27M

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $5.11B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account